In allograft monitoring of solid organ transplant recipients, liquid biopsy has emerged as a novel minimally invasive approach using quantification of cell-free DNA in plasma originating from the allograft, so-called donor-derived cfDNA (dd-cfDNA). Despite early clinical implementation and analytical…